Home Newsfeeds Keybanc Initiates Coverage On Allbirds with Sector Weight Rating

Keybanc Initiates Coverage On Allbirds with Sector Weight Rating

Keybanc analyst Noah Zatzkin initiates coverage on Allbirds (NASDAQ:BIRD) with a Sector Weight rating.

byBenzinga Newsdesk

July 21, 2022

1 minute read

Keybanc analyst Noah Zatzkin initiates coverage on Allbirds (NASDAQ:BIRD) with a Sector Weight rating.

RedHill’s Investigational COVID-19 Drugs Combined With Gilead’s Show Effect Against Ebola

By Vandana Singh

December 20, 2:01 PM

RedHill Biopharma Ltd (NASDAQ: RDHL) says opaganib and RHB-107 (upamostat) demonstrated robust synergistic effects when combined individually with Gilead Sciences Inc (NASDAQ: GILD) Veklury (remdesivir) i

GILD

Piper Sandler Maintains Overweight on PureTech Health, Raises Price Target to $44

By Benzinga Newsdesk

August 26, 6:55 AM

Piper Sandler analyst Edward Tenthoff maintains PureTech Health (NASDAQ:PRTC) with a Overweight and raises the price target from $37 to $44.

PRTC

Aethlon Medical Announces Investigation Of The Hemopurifier For Use In Organ Transplantation

By Happy Mohamed

June 21, 8:07 AM

Research to Confirm the Hemopurifier's Ability to Remove Harmful Viruses and Exosomes From Harvested Organs SAN DIEGO, June 21, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical

AEMD

Goldman Sachs Maintains Neutral on Definitive Healthcare, Lowers Price Target to $17

By Benzinga Newsdesk

November 7, 8:59 AM

Goldman Sachs analyst Kash Rangan maintains Definitive Healthcare (NASDAQ:DH) with a Neutral and lowers the price target from $31 to $17.

Keybanc Initiates Coverage On Allbirds with Sector Weight Rating

Related Posts

RedHill’s Investigational COVID-19 Drugs Combined With Gilead’s Show Effect Against Ebola

Piper Sandler Maintains Overweight on PureTech Health, Raises Price Target to $44

Aethlon Medical Announces Investigation Of The Hemopurifier For Use In Organ Transplantation

Goldman Sachs Maintains Neutral on Definitive Healthcare, Lowers Price Target to $17